262 related articles for article (PubMed ID: 24040208)
1. Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis.
Kawata K; Tsuda M; Yang GX; Zhang W; Tanaka H; Tsuneyama K; Leung P; He XS; Knechtle S; Ansari AA; Coppel RL; Gershwin ME
PLoS One; 2013; 8(9):e74225. PubMed ID: 24040208
[TBL] [Abstract][Full Text] [Related]
2. The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis.
Ambrosini YM; Yang GX; Zhang W; Tsuda M; Shu S; Tsuneyama K; Leung PS; Ansari AA; Coppel RL; Gershwin ME
Clin Exp Immunol; 2011 Oct; 166(1):110-20. PubMed ID: 21910728
[TBL] [Abstract][Full Text] [Related]
3. Innate immunity drives xenobiotic-induced murine autoimmune cholangitis.
Chang CH; Chen YC; Yu YH; Tao MH; Leung PS; Ansari AA; Gershwin ME; Chuang YH
Clin Exp Immunol; 2014 Aug; 177(2):373-80. PubMed ID: 24547942
[TBL] [Abstract][Full Text] [Related]
4. Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells.
Liaskou E; Patel SR; Webb G; Bagkou Dimakou D; Akiror S; Krishna M; Mells G; Jones DE; Bowman SJ; Barone F; Fisher BA; Hirschfield GM
J Autoimmun; 2018 Nov; 94():143-155. PubMed ID: 30119881
[TBL] [Abstract][Full Text] [Related]
5. The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice.
Ando Y; Yang GX; Tsuda M; Kawata K; Zhang W; Nakajima T; Tsuneyama K; Leung P; Lian ZX; Okazaki K; Ridgway WM; Norman GL; Ansari AA; He XS; Coppel RL; Gershwin ME
Hepatology; 2012 Oct; 56(4):1418-26. PubMed ID: 22532156
[TBL] [Abstract][Full Text] [Related]
6. Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice.
Yoshida K; Yang GX; Zhang W; Tsuda M; Tsuneyama K; Moritoki Y; Ansari AA; Okazaki K; Lian ZX; Coppel RL; Mackay IR; Gershwin ME
Hepatology; 2009 Nov; 50(5):1494-500. PubMed ID: 19676134
[TBL] [Abstract][Full Text] [Related]
7. Differential modulation by IL-17A of Cholangitis versus Colitis in IL-2Rα deleted mice.
Yang W; Yao Y; Yang YQ; Lu FT; Li L; Wang YH; Nakajima T; Tsuneyama K; Ridgway WM; Gershwin ME; Lian ZX
PLoS One; 2014; 9(8):e105351. PubMed ID: 25133396
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9.
Fan J; Tang X; Wang Q; Zhang Z; Wu S; Li W; Liu S; Yao G; Chen H; Sun L
Stem Cell Res Ther; 2018 Sep; 9(1):237. PubMed ID: 30223894
[TBL] [Abstract][Full Text] [Related]
9. Endogenous IL-10 maintains immune tolerance but IL-10 gene transfer exacerbates autoimmune cholangitis.
Hsueh YH; Chen HW; Syu BJ; Lin CI; Leung PSC; Gershwin ME; Chuang YH
J Autoimmun; 2018 Dec; 95():159-170. PubMed ID: 30274824
[TBL] [Abstract][Full Text] [Related]
10. IL-21, not IL-17A, exacerbates murine primary biliary cholangitis.
Chan CW; Chen HW; Wang YW; Lin CI; Chuang YH
Clin Exp Immunol; 2024 Feb; 215(2):137-147. PubMed ID: 37708215
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis.
Dhirapong A; Yang GX; Nadler S; Zhang W; Tsuneyama K; Leung P; Knechtle S; Ansari AA; Coppel RL; Liu FT; He XS; Gershwin ME
Hepatology; 2013 Feb; 57(2):708-15. PubMed ID: 22996325
[TBL] [Abstract][Full Text] [Related]
12. Dual Roles of IFN-γ and IL-4 in the Natural History of Murine Autoimmune Cholangitis: IL-30 and Implications for Precision Medicine.
Syu BJ; Loh CE; Hsueh YH; Gershwin ME; Chuang YH
Sci Rep; 2016 Oct; 6():34884. PubMed ID: 27721424
[TBL] [Abstract][Full Text] [Related]
13. Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice.
Tsuda M; Zhang W; Yang GX; Tsuneyama K; Ando Y; Kawata K; Park O; Leung PS; Coppel RL; Ansari AA; Ridgway WM; Gao B; Lian ZX; Flavell R; He XS; Gershwin ME
Hepatology; 2013 Feb; 57(2):806-16. PubMed ID: 22576253
[TBL] [Abstract][Full Text] [Related]
14. The Proinflammatory Cytokines IL-18, IL-21, and IFN-
Xu YF; Yao Y; Ma M; Yang SH; Jiang P; Wang J; Tsuneyama K; Wang C; Liu X; Li L; Lian ZX
J Immunol Res; 2022; 2022():7111445. PubMed ID: 35300072
[TBL] [Abstract][Full Text] [Related]
15. Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases.
Verdier J; Begue B; Cerf-Bensussan N; Ruemmele FM
Inflamm Bowel Dis; 2012 Jul; 18(7):1260-6. PubMed ID: 21994045
[TBL] [Abstract][Full Text] [Related]
16. Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis.
Wu SJ; Yang YH; Tsuneyama K; Leung PS; Illarionov P; Gershwin ME; Chuang YH
Hepatology; 2011 Mar; 53(3):915-25. PubMed ID: 21374662
[TBL] [Abstract][Full Text] [Related]
17. Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens.
Arsenijevic A; Milovanovic M; Milovanovic J; Stojanovic B; Zdravkovic N; Leung PS; Liu FT; Gershwin ME; Lukic ML
Sci Rep; 2016 Mar; 6():23348. PubMed ID: 26996208
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse.
Ando Y; Yang GX; Kenny TP; Kawata K; Zhang W; Huang W; Leung PS; Lian ZX; Okazaki K; Ansari AA; He XS; Invernizzi P; Ridgway WM; Lu Q; Gershwin ME
J Autoimmun; 2013 Mar; 41():111-9. PubMed ID: 23395552
[TBL] [Abstract][Full Text] [Related]
19. Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity.
Naiyanetr P; Butler JD; Meng L; Pfeiff J; Kenny TP; Guggenheim KG; Reiger R; Lam K; Kurth MJ; Ansari AA; Coppel RL; López-Hoyos M; Gershwin ME; Leung PS
J Autoimmun; 2011 Nov; 37(3):209-16. PubMed ID: 21763105
[TBL] [Abstract][Full Text] [Related]
20. IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy.
Yang CY; Ma X; Tsuneyama K; Huang S; Takahashi T; Chalasani NP; Bowlus CL; Yang GX; Leung PS; Ansari AA; Wu L; Coppel RL; Gershwin ME
Hepatology; 2014 May; 59(5):1944-53. PubMed ID: 24375552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
